Domain EYEION.com for sale! This premium domain is available now at Kadomain.com

Safe water tool nearly three times more effective than standard practice, new study finds

  • medicalxpress.com language
  • 2025-08-21 23:52 event
  • 2 days ago schedule
Safe water tool nearly three times more effective than standard practice, new study finds
A new study finds a dramatic increase in safe drinking water when a machine learning-enabled tool created by York University researchers is used to optimize chlorination levels in refugee camp water supplies. Lead author Syed Imran Ali says that the new study shows that the Safe Water Optimization Tool (SWOT) vastly outperforms status-quo guidelines for safe water supply in humanitarian response.

59. Improving prediction of worsening knee osteoarthritis with an AI-assisted model

  • 2 days ago schedule
  • medicalxpress.com language

An artificial intelligence (AI)-assisted model that combines a patient's MRI, biochemical, and clinical information shows preliminary promise in improving predictions of whether their knee osteoarthritis may soon worsen. Ting Wang of Chongqing Medical University, China, and colleagues have published this model in the journal PLOS Medicine.

60. Study suggests no link between antibiotic exposure and autoimmune diseases in children

  • 2 days ago schedule
  • medicalxpress.com language

The global incidence of autoimmune diseases among children has increased over the past few decades. A study published in the open-access journal PLOS Medicine by Ju-Young Shin at Sungkyunkwan University, Republic of Korea, and colleagues suggests that early life antibiotic exposure is not associated with an increased risk of autoimmune diseases in children.

61. Metabolic syndrome linked to increased risk for Parkinson's disease

  • 2 days ago schedule
  • medicalxpress.com language

Metabolic syndrome (MetS) is associated with an increased risk for Parkinson's disease (PD), according to a study published online Aug. 20 in Neurology.

62. FDA approves papzimeos for adults with recurrent respiratory papillomatosis

  • 2 days ago schedule
  • medicalxpress.com language

The U.S. Food and Drug Administration has approved Papzimeos (zopapogene imadenovec-drba) for the treatment of adults with recurrent respiratory papillomatosis (RRP).

63. Infections from flesh-eating bacteria are spreading to new areas

  • 2 days ago schedule
  • medicalxpress.com language

Health experts across the country are issuing warnings about a surge in infections from a "flesh-eating" bacterium known as Vibrio vulnificus.

64. Worse emotional health-related quality of life seen for women with cirrhosis, ascites

  • 2 days ago schedule
  • medicalxpress.com language

Women with cirrhosis and ascites experience worse health-related quality of life (HRQoL) than men, although no difference is seen in daily function, according to a study published in the August issue of the American Journal of Gastroenterology.

65. Dual-mode tracer could enable surgeons to see and 'hear' prostate cancer

  • 2 days ago schedule
  • medicalxpress.com language

A preclinical evaluation of a new "dual-mode" tracer agent shows promise in not only helping surgeons image and plan prostate cancer procedures, but also provide them with much more consistent and targeted guidance during surgery.

66. Cold plasma penetrates deep into tissue to fight cancer

  • 2 days ago schedule
  • medicalxpress.com language

Researchers at the Leibniz Institute for Plasma Science and Technology (INP) have collaborated with partners at Greifswald University Hospital and University Medical Center Rostock to demonstrate that cold plasma can effectively combat tumor cells even in deeper tissue layers.

67. Molgramostim beneficial in autoimmune pulmonary alveolar proteinosis

  • 2 days ago schedule
  • medicalxpress.com language

In adults with autoimmune pulmonary alveolar proteinosis (aPAP), once-daily inhaled molgramostim, a recombinant human granulocyte-macrophage colony-stimulating factor, leads to a greater increase in pulmonary gas transfer than placebo, according to a study published in the Aug. 21/28 issue of the New England Journal of Medicine.

68. Safe water tool nearly three times more effective than standard practice, new study finds

  • 2 days ago schedule
  • medicalxpress.com language

A new study finds a dramatic increase in safe drinking water when a machine learning-enabled tool created by York University researchers is used to optimize chlorination levels in refugee camp water supplies. Lead author Syed Imran Ali says that the new study shows that the Safe Water Optimization Tool (SWOT) vastly outperforms status-quo guidelines for safe water supply in humanitarian response.

69. California resident infected with plague, likely from flea at Lake Tahoe

  • 2 days ago schedule
  • medicalxpress.com language

A resident of South Lake Tahoe, California, has been diagnosed with the plague, the state's first human plague infection since 2020.

70. CDC to lay off hundreds in restructuring

  • 2 days ago schedule
  • medicalxpress.com language

The U.S. Centers for Disease Control and Prevention (CDC) is finalizing the termination of at least 600 employees this week, including some working in violence prevention programs.

71. Combination therapy improves outcomes for advanced triple-negative breast cancer

  • 2 days ago schedule
  • medicalxpress.com language

A new study led by researchers at the Icahn School of Medicine at Mount Sinai has found that adding the targeted therapy everolimus to standard carboplatin chemotherapy extends the time before disease progression in patients with advanced triple-negative breast cancer (TNBC), one of the most aggressive and hard-to-treat forms of breast cancer.

72. How AI will transform mental health support for patients with breast cancer

  • 2 days ago schedule
  • medicalxpress.com language

From virtual counselors that can hear depression creeping into a person's voice to smart watches that can detect stress, artificial intelligence is poised to revolutionize mental health care for patients with breast cancer.

73. Sleep apnea and the unlikely role of conch shells

  • 2 days ago schedule
  • medicalxpress.com language

Could blowing a conch shell help treat sleep apnea? As a doctor working in sleep medicine, this unexpected news story certainly grabbed my attention. My first reaction was skepticism—sleep specialists don't typically prescribe natural objects found on beaches as medical therapy. But perhaps I was too hasty to dismiss the idea.

74. Weather disasters increase risk for US drug supply chain disruption, research shows

  • 2 days ago schedule
  • medicalxpress.com language

In 2024, Hurricane Helene triggered a nationwide shortage of the country's intravenous (IV) fluids after damaging a facility in North Carolina. A similar IV fluid shortage was caused when Hurricane Maria hit Puerto Rico in 2017.

75. Novel technique scans for health cues using light and skin

  • 2 days ago schedule
  • medicalxpress.com language

A handheld sensor and innovative technique developed by Texas A&M AgriLife Research scientists could one day offer a noninvasive alternative to food diaries and blood tests when monitoring diet and health.

76. First targeted therapy for rare T-cell lymphoma after CAR T treatment successful

  • 2 days ago schedule
  • medicalxpress.com language

A team of researchers from The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai has successfully treated a rare and aggressive T-cell lymphoma that developed after CAR T-cell therapy for multiple myeloma, marking a first in the field of hematologic cancer research. The findings were published in the New England Journal of Medicine.

77. New CT-based indicator helps doctors predict life-threatening postpartum bleeding cases

  • 2 days ago schedule
  • medicalxpress.com language

Researchers from Kumamoto University have identified a distinctive CT imaging pattern that can predict which women experiencing severe postpartum hemorrhage (PPH) are most likely to need life-saving interventions.

Cookie Policy

We use cookies and similar technologies to help the site provide a better user experience. By using the website you agree to our Cookie Policy, Terms of Use and Privacy Policy.